Ring 1
Ring 2
Ring 3
Ring 4

Recursion Pharma

Financing Rounds

  • Series D+
  • Public
Round Led by Symbiosis
Round Led by Symbiosis

Recursion is a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development and beyond through disruptive innovation. Enabling its mission is the Recursion Operating System, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets, the Recursion Data Universe. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset the Recursion Map, a collection of hundreds of billions of searchable inferences across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.

recursion View Website

Modality

  • Small Molecule

Indications

  • Circulatory & Metabolic Disease
  • Infectious Disease
  • Neurology
  • Oncology
  • Other

Development Status

  • Phase 2